Daniil Gataulin
Stock Analyst at Chardan Capital
(2.71)
# 2,707
Out of 4,396 analysts
75
Total ratings
32.3%
Success rate
2.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRVO CervoMed | Reiterated: Buy | $21 | $2.89 | +626.64% | 7 | May 17, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $36 → $35 | $9.21 | +280.02% | 2 | May 14, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $9 → $11 | $4.08 | +169.61% | 2 | May 13, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | $51 → $53 | $10.98 | +382.70% | 3 | May 12, 2026 | |
| FBRX Forte Biosciences | Reiterated: Buy | $61 | $17.00 | +258.82% | 3 | May 11, 2026 | |
| KOD Kodiak Sciences | Upgraded: Buy | $14 → $61 | $31.06 | +96.39% | 6 | May 11, 2026 | |
| CGTX Cognition Therapeutics | Reiterated: Buy | $8 → $4 | $1.15 | +247.83% | 3 | May 8, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $5 → $7 | $1.24 | +464.52% | 8 | May 7, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $10 → $11 | $3.69 | +198.10% | 4 | May 7, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $29 | $11.77 | +146.39% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $8.47 | +147.93% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $26.46 | +39.83% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $6.34 | +720.19% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $0.7047 | +41.90% | 6 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $5.20 | +207.69% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $4.09 | +365.12% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.01 | - | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0824 | - | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.94 | n/a | 2 | Feb 15, 2023 |
CervoMed
May 17, 2026
Reiterated: Buy
Price Target: $21
Current: $2.89
Upside: +626.64%
MeiraGTx Holdings
May 14, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $9.21
Upside: +280.02%
Opus Genetics
May 13, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $4.08
Upside: +169.61%
Oculis Holding AG
May 12, 2026
Reiterated: Buy
Price Target: $51 → $53
Current: $10.98
Upside: +382.70%
Forte Biosciences
May 11, 2026
Reiterated: Buy
Price Target: $61
Current: $17.00
Upside: +258.82%
Kodiak Sciences
May 11, 2026
Upgraded: Buy
Price Target: $14 → $61
Current: $31.06
Upside: +96.39%
Cognition Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $8 → $4
Current: $1.15
Upside: +247.83%
Ocugen
May 7, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $1.24
Upside: +464.52%
Zura Bio
May 7, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $3.69
Upside: +198.10%
EyePoint
May 6, 2026
Reiterated: Buy
Price Target: $29
Current: $11.77
Upside: +146.39%
May 6, 2026
Reiterated: Buy
Price Target: $21
Current: $8.47
Upside: +147.93%
May 5, 2026
Reiterated: Buy
Price Target: $37
Current: $26.46
Upside: +39.83%
Jan 28, 2026
Reiterated: Buy
Price Target: $52
Current: $6.34
Upside: +720.19%
Jan 2, 2026
Maintained: Hold
Price Target: $3 → $1
Current: $0.7047
Upside: +41.90%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $5.20
Upside: +207.69%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $4.09
Upside: +365.12%
Jul 17, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.01
Upside: -
Jun 13, 2025
Maintained: Hold
Price Target: n/a
Current: $0.0824
Upside: -
Feb 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $10.94
Upside: n/a